13F-HR filed by Flagship Pioneering, LLC
Flagship Pioneering, LLC filed this 13F-HR for the quarter ended 2017-09-30, filed 2017-11-03, with 4 holding rows worth $298,998,000.
- Accession
- 0001012975-17-000806
- Filer
- CIK 1400240
- Filed
- 2017-11-03
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2017
A holdings report, 5 entries on the cover page, a total value of $298,998,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $298,998,000 with VALUE read as thousands by filing date, 13F file number 028-17559. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFlagship Ventures 2007 General Partner LLC028-15778
- included managerFlagship Ventures Fund IV General Partner LLC028-17238
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SERES THERAPEUTICS INC | 81750R102 | COM | 12,682,876 | $203,433,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 3,204,437 | $47,169,000 | thousands by filing date | |
| EDITAS MEDICINE INC | 28106W103 | COM | 1,674,435 | $40,203,000 | thousands by filing date | |
| TTOO | 89853L104 | Stock | 1,950,583 | $8,193,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001012975-17-000806 | this filing | 2017-11-03 | acceptance time not in the bulk data set |